CJC1295 DAC - Hubio Pharm

CJC-1295 with DAC was originally developed to treat growth hormone deficiency by stimulating the pituitary gland. Though never FDA-approved, it remains under research. Today, CJC-1295 with DAC is widely used in performance and anti-aging communities to boost natural GH and IGF-1 levels. Its long half-life allows infrequent dosing. It is not a post-cycle therapy (PCT) drug and does not replace testosterone. The compound gained popularity in the 2000s after clinical trials showed sustained GH release.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about CJC1295 DAC by Hubio Pharm, consult with your doctor or healthcare professional.